These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15179158)

  • 1. Asthma medication in Finnish olympic athletes: no signs of inhaled beta2-agonist overuse.
    Alaranta A; Alaranta H; Palmu P; Alha P; Pietilä K; Heliövaara M; Helenius I
    Med Sci Sports Exerc; 2004 Jun; 36(6):919-24. PubMed ID: 15179158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asthma medication is increasingly prescribed for finnish olympic athletes--for a reason?
    Aavikko A; Helenius I; Alaranta A; Vasankari T; Haahtela T
    J Asthma; 2012 Sep; 49(7):744-9. PubMed ID: 22873287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic rhinitis and pharmacological management in elite athletes.
    Alaranta A; Alaranta H; Heliövaara M; Alha P; Palmu P; Helenius I
    Med Sci Sports Exerc; 2005 May; 37(5):707-11. PubMed ID: 15870621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta2-Agonists at the Olympic Games.
    Fitch KD
    Clin Rev Allergy Immunol; 2006; 31(2-3):259-68. PubMed ID: 17085798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do inhaled beta(2)-agonists have an ergogenic potential in non-asthmatic competitive athletes?
    Kindermann W
    Sports Med; 2007; 37(2):95-102. PubMed ID: 17241101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaceutical treatment of asthma symptoms in elite athletes - doping or therapy?
    Backer V; Lund T; Pedersen L
    Scand J Med Sci Sports; 2007 Dec; 17(6):615-22. PubMed ID: 18093034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled beta2 agonists and performance in competitive athletes.
    Kindermann W; Meyer T
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i43-7. PubMed ID: 16799103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of anti-asthmatic medication among Danish elite athletes].
    Lund TK; Pedersen L; Backer V
    Ugeskr Laeger; 2007 Dec; 169(50):4355-9. PubMed ID: 18211794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of asthma-like symptoms, asthma and its treatment in elite athletes.
    Lund T; Pedersen L; Larsson B; Backer V
    Scand J Med Sci Sports; 2009 Apr; 19(2):174-8. PubMed ID: 18282226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ergogenic effects of inhaled beta2-agonists in non-asthmatic athletes.
    Wolfarth B; Wuestenfeld JC; Kindermann W
    Endocrinol Metab Clin North Am; 2010 Mar; 39(1):75-87, ix. PubMed ID: 20122451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma in elite athletes: how do we manage asthma-like symptoms and asthma in elite athletes?
    Lund TK
    Clin Respir J; 2009 Apr; 3(2):123. PubMed ID: 20298392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The asthmatic athlete: inhaled Beta-2 agonists, sport performance, and doping.
    McKenzie DC; Fitch KD
    Clin J Sport Med; 2011 Jan; 21(1):46-50. PubMed ID: 21200170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can asthma treatment in sports be doping? The effect of the rapid onset, long-acting inhaled beta2-agonist formoterol upon endurance performance in healthy well-trained athletes.
    Carlsen KH; Hem E; Stensrud T; Held T; Herland K; Mowinckel P
    Respir Med; 2001 Jul; 95(7):571-6. PubMed ID: 11453313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchial challenges in athletes applying to inhale a beta2-agonist at the 2004 Summer Olympics.
    Anderson SD; Sue-Chu M; Perry CP; Gratziou C; Kippelen P; McKenzie DC; Beck KC; Fitch KD
    J Allergy Clin Immunol; 2006 Apr; 117(4):767-73. PubMed ID: 16630932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment patterns among adult patients with asthma: factors associated with overuse of inhaled beta-agonists and underuse of inhaled corticosteroids.
    Diette GB; Wu AW; Skinner EA; Markson L; Clark RD; McDonald RC; Healy JP; Huber M; Steinwachs DM
    Arch Intern Med; 1999 Dec 13-27; 159(22):2697-704. PubMed ID: 10597760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The asthmatic athlete, inhaled beta agonists, and performance.
    McKenzie DC; Stewart IB; Fitch KD
    Clin J Sport Med; 2002 Jul; 12(4):225-8. PubMed ID: 12131055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why must olympic athletes prove that they have asthma to be permitted to take inhaled beta2-agonists?
    Weiler JM
    J Allergy Clin Immunol; 2003 Jan; 111(1):36-7. PubMed ID: 12532093
    [No Abstract]   [Full Text] [Related]  

  • 18. Snuff use and smoking in Finnish olympic athletes.
    Alaranta A; Alaranta H; Patja K; Palmu P; Prättälä R; Martelin T; Helenius I
    Int J Sports Med; 2006 Jul; 27(7):581-6. PubMed ID: 16802255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of asthma and airway hyper-responsiveness in Olympic athletes.
    Fitch KD
    Br J Sports Med; 2012 May; 46(6):413-6. PubMed ID: 22228581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
    Ni CM; Greenstone IR; Ducharme FM
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.